[go: up one dir, main page]

FR2769322B1 - NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS - Google Patents

NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS

Info

Publication number
FR2769322B1
FR2769322B1 FR9800873A FR9800873A FR2769322B1 FR 2769322 B1 FR2769322 B1 FR 2769322B1 FR 9800873 A FR9800873 A FR 9800873A FR 9800873 A FR9800873 A FR 9800873A FR 2769322 B1 FR2769322 B1 FR 2769322B1
Authority
FR
France
Prior art keywords
vaccines
diagnostic reagents
porcine circoviruses
new porcine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9800873A
Other languages
French (fr)
Other versions
FR2769322A1 (en
Inventor
Gordon Allan
Brian Meehan
Edward Clark
John Ellis
Deborah Haines
Lori Hassard
John Harding
Catherine Elisabeth Charreyre
Gilles Emile Chappuis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9712382A external-priority patent/FR2769321B1/en
Priority to UA2000042372A priority Critical patent/UA78180C2/en
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Priority to FR9800873A priority patent/FR2769322B1/en
Priority to US09/082,558 priority patent/US6368601B1/en
Priority to US09/161,092 priority patent/US6391314B1/en
Priority to PT98946547T priority patent/PT1019510E/en
Priority to AT02017134T priority patent/ATE299531T1/en
Priority to CN200910252636.4A priority patent/CN101724606B/en
Priority to KR1020097009112A priority patent/KR100944144B1/en
Priority to KR1020087004310A priority patent/KR100904852B1/en
Priority to DK05014998.8T priority patent/DK1741785T3/en
Priority to BRPI9812845-0A priority patent/BR9812845B1/en
Priority to RU2000111496A priority patent/RU2283862C2/en
Priority to ES02017134T priority patent/ES2246001T3/en
Priority to DE69830858T priority patent/DE69830858T4/en
Priority to PT02017134T priority patent/PT1281760E/en
Priority to KR1020007003628A priority patent/KR100736129B1/en
Priority to CA002305623A priority patent/CA2305623C/en
Priority to PT03016998T priority patent/PT1386617E/en
Priority to AT03016998T priority patent/ATE387914T1/en
Priority to ES03016998T priority patent/ES2302885T3/en
Priority to AU93555/98A priority patent/AU756554C/en
Priority to ES05014998.8T priority patent/ES2524359T3/en
Priority to EP98946547A priority patent/EP1019510B1/en
Priority to CN98810652A priority patent/CN100584948C/en
Priority to PL339631A priority patent/PL198506B1/en
Priority to HU0800330A priority patent/HU230340B1/en
Priority to DK98946547T priority patent/DK1019510T3/en
Priority to DE69816460T priority patent/DE69816460T2/en
Priority to CN2008101690507A priority patent/CN101445802B/en
Priority to EP02017134A priority patent/EP1281760B9/en
Priority to DK02017134T priority patent/DK1281760T5/en
Priority to EP05014998.8A priority patent/EP1741785B1/en
Priority to KR1020067010174A priority patent/KR100854615B1/en
Priority to DE200512000009 priority patent/DE122005000009I1/en
Priority to DK03016998T priority patent/DK1386617T3/en
Priority to DE69839227T priority patent/DE69839227T2/en
Priority to DE69830858A priority patent/DE69830858D1/en
Priority to PCT/FR1998/002107 priority patent/WO1999018214A1/en
Priority to AT98946547T priority patent/ATE245191T1/en
Priority to EP03016998A priority patent/EP1386617B1/en
Priority to DE05014998T priority patent/DE05014998T1/en
Priority to JP2000515010A priority patent/JP5008218B2/en
Priority to HU0003756A priority patent/HU226247B1/en
Priority to DE122008000069C priority patent/DE122008000069I1/en
Priority to ES98946547T priority patent/ES2203984T3/en
Priority to PT50149988T priority patent/PT1741785E/en
Publication of FR2769322A1 publication Critical patent/FR2769322A1/en
Priority to US09/884,514 priority patent/US6660272B2/en
Application granted granted Critical
Publication of FR2769322B1 publication Critical patent/FR2769322B1/en
Priority to US10/624,049 priority patent/US7122192B2/en
Priority to US10/653,849 priority patent/US7192594B2/en
Priority to US10/780,318 priority patent/US7211379B2/en
Priority to US11/107,219 priority patent/US20060029617A1/en
Priority to FR05C0021C priority patent/FR05C0021I2/fr
Priority to US11/217,562 priority patent/US7504206B2/en
Priority to CY20051101221T priority patent/CY1110359T1/en
Priority to US11/485,240 priority patent/US7833783B2/en
Priority to US11/485,525 priority patent/US7803613B2/en
Priority to US11/522,237 priority patent/US7803926B2/en
Priority to HK07101074.0A priority patent/HK1095161A1/en
Priority to JP2007254101A priority patent/JP4680245B2/en
Priority to NL300326C priority patent/NL300326I2/en
Priority to CY20081100583T priority patent/CY1108113T1/en
Priority to JP2011004965A priority patent/JP5362750B2/en
Priority to JP2012060619A priority patent/JP2012193179A/en
Priority to CY20141100947T priority patent/CY1115749T1/en
Priority to JP2014255849A priority patent/JP5869658B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0321—Propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation
    • C12N2750/10064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9800873A 1997-10-03 1998-01-22 NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS Expired - Lifetime FR2769322B1 (en)

Priority Applications (65)

Application Number Priority Date Filing Date Title
UA2000042372A UA78180C2 (en) 1997-10-03 1998-01-10 Porcine circovirus, vaccines and diagnostic reagents
FR9800873A FR2769322B1 (en) 1997-10-03 1998-01-22 NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS
US09/082,558 US6368601B1 (en) 1997-10-03 1998-05-21 Porcine circovirus vaccine and diagnostics reagents
US09/161,092 US6391314B1 (en) 1997-10-03 1998-09-25 Porcine circoviruses vaccines diagnostic reagents
PT98946547T PT1019510E (en) 1997-10-03 1998-10-01 DERIVED VACCINES OF SWINE CIRCUVIRUS
AT02017134T ATE299531T1 (en) 1997-10-03 1998-10-01 SWINE CIRCOVIRUSES
CN200910252636.4A CN101724606B (en) 1997-10-03 1998-10-01 Procine circoviruses, vaccine and diagnostic reagent
KR1020097009112A KR100944144B1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
KR1020087004310A KR100904852B1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
DK05014998.8T DK1741785T3 (en) 1997-10-03 1998-10-01 Porcine circovirus, nucleic acids, polypeptides and vaccines
BRPI9812845-0A BR9812845B1 (en) 1997-10-03 1998-10-01 vaccine inducing an immune response to suine type II circovirus.
RU2000111496A RU2283862C2 (en) 1997-10-03 1998-10-01 Ii type porcine circovirus and uses thereof
ES02017134T ES2246001T3 (en) 1997-10-03 1998-10-01 SWINE CIRCOVIRUS.
DE69830858T DE69830858T4 (en) 1997-10-03 1998-10-01 Schweinecircoviren
PT02017134T PT1281760E (en) 1997-10-03 1998-10-01 PORCINE CIRCUVIRUS, VACCINES AND DIAGNOSTIC REAGENTS
KR1020007003628A KR100736129B1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
CA002305623A CA2305623C (en) 1997-10-03 1998-10-01 Porcine circovirus, vaccines, and diagnostic reagents
PT03016998T PT1386617E (en) 1997-10-03 1998-10-01 Method for the in vitro diagnosis of type ii porcine circovirus infection and diagnostic reagents
AT03016998T ATE387914T1 (en) 1997-10-03 1998-10-01 METHOD FOR IN VITRO DIAGNOSIS OF INFECTIONS CAUSED BY TYPE II SWINE CIRCOVIRUS AND DIAGNOSTIC REAGENTS
ES03016998T ES2302885T3 (en) 1997-10-03 1998-10-01 IN VITRO DIAGNOSTIC METHOD OF TYPE II SWINE CIRCOVIRUS INFECTION AND DIAGNOSTIC REAGENTS.
AU93555/98A AU756554C (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
ES05014998.8T ES2524359T3 (en) 1997-10-03 1998-10-01 Porcine circovirus, nucleic acids, polypeptides and vaccines
EP98946547A EP1019510B1 (en) 1997-10-03 1998-10-01 Vaccines derived from porcine circoviruses
CN98810652A CN100584948C (en) 1997-10-03 1998-10-01 New porcine ring virus, vaccine and diagnostic reagent
PL339631A PL198506B1 (en) 1997-10-03 1998-10-01 Swine's cicroviruses, vaccines and diagnostic reagents
HU0800330A HU230340B1 (en) 1997-10-03 1998-10-01 Expression vectors containing sequences from porcine circoviruses and vaccines contaning thereof
DK98946547T DK1019510T3 (en) 1997-10-03 1998-10-01 Vaccines based on porcine circovirus
DE69816460T DE69816460T2 (en) 1997-10-03 1998-10-01 PIG CIRCOVIRUS-DERIVED VACCINE
CN2008101690507A CN101445802B (en) 1997-10-03 1998-10-01 Novel porcine circovirus virus, vaccines and diagnosis agent
EP02017134A EP1281760B9 (en) 1997-10-03 1998-10-01 Porcine circoviruses
DK02017134T DK1281760T5 (en) 1997-10-03 1998-10-01 Porcine circovirus
EP05014998.8A EP1741785B1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, nucleic acids, polypeptides and vaccines
KR1020067010174A KR100854615B1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
DE200512000009 DE122005000009I1 (en) 1997-10-03 1998-10-01 Pigs circovirus derived vaccines.
DK03016998T DK1386617T3 (en) 1997-10-03 1998-10-01 Method for in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents
DE69839227T DE69839227T2 (en) 1997-10-03 1998-10-01 A method for the in vitro diagnosis of type II porcine circovirus infections and diagnostic reagents
DE69830858A DE69830858D1 (en) 1997-10-03 1998-10-01 Schweinecircoviren
PCT/FR1998/002107 WO1999018214A1 (en) 1997-10-03 1998-10-01 Porcine circoviruses, vaccines and diagnostic reagents
AT98946547T ATE245191T1 (en) 1997-10-03 1998-10-01 SWINE CIRCOVIRUS DERIVED VACCINES
EP03016998A EP1386617B1 (en) 1997-10-03 1998-10-01 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents
DE05014998T DE05014998T1 (en) 1997-10-03 1998-10-01 Porcine circulating viruses, nucleic acids, polypeptides and vaccines
JP2000515010A JP5008218B2 (en) 1997-10-03 1998-10-01 Porcine circovirus, vaccine and diagnostic reagents
HU0003756A HU226247B1 (en) 1997-10-03 1998-10-01 Newly isolated porcine circoviruses, circovirus vaccines and diagnostic reagents
DE122008000069C DE122008000069I1 (en) 1997-10-03 1998-10-01 PIG ECONOMIC DERIVED VACCINES
ES98946547T ES2203984T3 (en) 1997-10-03 1998-10-01 VACCINES BASED ON SWINE CIRCOVIRUS.
PT50149988T PT1741785E (en) 1997-10-03 1998-10-01 Porcine circoviruses, nucleic acids, polypeptides and vaccines
US09/884,514 US6660272B2 (en) 1997-10-03 2001-06-19 Porcine circoviruses, vaccines and diagnostic reagents
US10/624,049 US7122192B2 (en) 1997-10-03 2003-07-21 Porcine circoviruses, vaccines and diagnostic reagents
US10/653,849 US7192594B2 (en) 1997-10-03 2003-09-02 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US10/780,318 US7211379B2 (en) 1997-10-03 2004-02-17 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US11/107,219 US20060029617A1 (en) 1997-10-03 2005-04-15 Porcine circovirus and Helicobacter combination vaccines and methods of use
FR05C0021C FR05C0021I2 (en) 1997-10-03 2005-04-26
US11/217,562 US7504206B2 (en) 1997-10-03 2005-09-01 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
CY20051101221T CY1110359T1 (en) 1997-10-03 2005-10-07 CIRCULAR SWINE-based vaccine
US11/485,240 US7833783B2 (en) 1997-10-03 2006-07-12 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/485,525 US7803613B2 (en) 1997-10-03 2006-07-12 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/522,237 US7803926B2 (en) 1997-10-03 2006-09-15 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
HK07101074.0A HK1095161A1 (en) 1997-10-03 2007-01-31 Porcine circoviruses, nucleic acids, polypeptides and vaccines
JP2007254101A JP4680245B2 (en) 1997-10-03 2007-09-28 Porcine circovirus, vaccine and diagnostic reagents
NL300326C NL300326I2 (en) 1997-10-03 2007-12-18 Circovirus in pigs, vaccines and diagnostic reagents
CY20081100583T CY1108113T1 (en) 1997-10-03 2008-06-03 IN VITRO DIAGNOSIS METHOD OF INFECTION FROM TYPE II SWIRC SURGERY AND DIAGNOSTIC REAGENTS
JP2011004965A JP5362750B2 (en) 1997-10-03 2011-01-13 Porcine circovirus, vaccine and diagnostic reagents
JP2012060619A JP2012193179A (en) 1997-10-03 2012-03-16 Porcine circovirus, vaccine, and diagnostic reagent
CY20141100947T CY1115749T1 (en) 1997-10-03 2014-11-13 SWINE CYCLE, NUCLEAR ACIDS, POLYPALPTES AND VACCINES
JP2014255849A JP5869658B2 (en) 1997-10-03 2014-12-18 Porcine circovirus, vaccine and diagnostic reagents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9712382A FR2769321B1 (en) 1997-10-03 1997-10-03 NEW PIG CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS
FR9800873A FR2769322B1 (en) 1997-10-03 1998-01-22 NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS

Publications (2)

Publication Number Publication Date
FR2769322A1 FR2769322A1 (en) 1999-04-09
FR2769322B1 true FR2769322B1 (en) 2002-03-08

Family

ID=26233844

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9800873A Expired - Lifetime FR2769322B1 (en) 1997-10-03 1998-01-22 NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS

Country Status (2)

Country Link
FR (1) FR2769322B1 (en)
RU (1) RU2283862C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741026B2 (en) 1997-12-05 2010-06-22 Wyeth Circovirus sequences associated with piglet weight loss disease (PWD)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6497883B1 (en) * 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
DE10044648A1 (en) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Process for the propagation or removal of Cirocoviruses from biological material
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
HUE046045T2 (en) * 2004-12-30 2020-01-28 Boehringer Ingelheim Animal Health Usa Inc Pcv2 immunogenic compositions and methods of producing such compositions
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CL2008003813A1 (en) * 2007-12-21 2009-03-20 Zoetis W Llc Porcine circovirus; nucleic acid molecule that encodes it; immunogenic composition comprising it; method to immunize a pig against viral infection or to prevent post-weaning syndrome of multi-system wasting (pmsw), and method to determine if a mammal has or is at risk of developing pmsw.
BR102013001893B1 (en) * 2013-01-25 2022-01-25 Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig Recombinant porcine circovirus 2 (pcv-2) antigens for vaccine formulations, diagnostic kit and use
BR112016006192A2 (en) 2013-09-25 2017-09-26 Zoetis Services Llc pcv2b divergent vaccine composition and methods of use
WO2017066772A1 (en) * 2015-10-16 2017-04-20 Kansas State University Research Foundation Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
RU2695330C1 (en) * 2018-06-19 2019-07-23 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" Diagnostic technique for swine circovirus disease of the second type with direct immunohistochemical analysis on the basis of monoclonal antibodies
RU2697849C1 (en) * 2019-04-26 2019-08-21 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" (ФГБНУ ВНИТИБП) Diagnostic technique for porcine circovirus
RU2746142C1 (en) * 2020-06-23 2021-04-07 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Porcine circovirus strain "pcv2/shbc" for production of preventional and diagnostic preparations

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741026B2 (en) 1997-12-05 2010-06-22 Wyeth Circovirus sequences associated with piglet weight loss disease (PWD)
US7740866B2 (en) 1997-12-05 2010-06-22 Wyeth Circovirus sequences associated with piglet weight loss disease (PWD)
US7758865B2 (en) 1997-12-05 2010-07-20 Wyeth Circovirus sequences associated with piglet weight loss disease (PWD)
US7951907B2 (en) 1997-12-05 2011-05-31 Wyeth Llc Circovirus sequences associated with piglet weight loss disease (PWD)
US8124723B2 (en) 1997-12-05 2012-02-28 Wyeth Llc Circovirus sequences associated with piglet weight loss disease (PWD)
US8415525B2 (en) 1997-12-05 2013-04-09 Zoetis W Llc Circovirus sequences associated with piglet weight loss disease (PWD)
US8715690B2 (en) 1997-12-05 2014-05-06 Zoetis W Llc Circovirus sequences associated with piglet weight loss disease (PWD)
US8916353B2 (en) 1997-12-05 2014-12-23 Zoetis W Llc Circovirus sequences associated with piglet weight loss disease (PWD)

Also Published As

Publication number Publication date
FR2769322A1 (en) 1999-04-09
RU2283862C2 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
HUP0003756A3 (en) Porcine circoviruses, vaccines and diagnostic reagents
HUP0102770A3 (en) Porcine circovirus and parvovirus vaccine
FR2769322B1 (en) NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS
HUP0201689A3 (en) Porcine circovirus vaccine in reconbinant poxvirus
ITTO950367A0 (en) RECOMBINANT PRRSV PROTEINS, DIAGNOSTIC KITS AND VACCINES CONTAINING SUCH RECOMBINANT PRRSV PROTEINS.
DE69729184D1 (en) VACCINE AGAINST CLOSTRIDIUM PERFRINGENS
DE69827773D1 (en) TUBUS FOR BIOPSY TONGS WITH FLUSHING AND SUCTION CAPABILITIES
ATE357459T1 (en) ANTIBODIES TO HUMAN IL-12
GB9811433D0 (en) Virus vaccine
IL139890A0 (en) Method for the collection and initial preparation of tissue samples for molecular genetic diagnostics
EP1083926A4 (en) VACCINE
DE60013983D1 (en) Multi-channel pipette system and pipette tips therefor
EP1529059A4 (en) PROTEIN, ANTI-SENSE OLIGONUCLEOTIDE AND PORCINE LEPTIN ANTIBODY
MA25489A1 (en) VACCINES
IT238006Y1 (en) HIGH STRUCTURAL SIMPLICITY MASSAGE DEVICE, USABLE DIRECTLY OR INSERTABLE INSIDE THE BACKREST
FR2776928B1 (en) ADJUVATED DNA VACCINES
DE69737231D1 (en) VACCINATION WITH NUCLEIC ACIDS AGAINST PARVOVIRUS INFECTIONS
BR0010418B1 (en) Salmonella microorganism, vaccine composition and use of said microorganism.
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
AU5389898A (en) Canine parvovirus DNA vaccines
BR0000687B1 (en) Disposable intimate part.
FR2769321B1 (en) NEW PIG CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS
EP1186615A4 (en) Novel protein and dna thereof
DE69526203D1 (en) BIOLOGICAL TARGETED AGENTS
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20